Browsing Tag
NASDAQ:SCNX
1 post
Scienture starts commercial rollout of Arbli, the first FDA-approved losartan oral suspension
Find out how Scienture is changing the hypertension treatment market with the FDA-approved Arbli losartan oral suspension.